Cargando…
Therapeutic targeting of HCMV-encoded chemokine receptor US28: Progress and challenges
The pervasive human cytomegalovirus (HCMV) causes significant morbidity in immunocompromised individuals. Treatment using the current standard-of-care (SOC) is limited by severe toxic adverse effects and anti-viral resistance development. Furthermore, they only affect HCMV in its lytic phase, meanin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968965/ https://www.ncbi.nlm.nih.gov/pubmed/36860859 http://dx.doi.org/10.3389/fimmu.2023.1135280 |